Optimized Single-Core PCF-Based SPR Biosensor for High-Performance Early-Stage Multi-Cancer Detection
Fuente:
arXiv
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | Preprint |
| Publicado: |
2025
|
| Materias: | |
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| _version_ | 1866914232390385664 |
|---|---|
| author | Malakar, Tonmoy Amina, Miss Nourin Nurain Nijhum, Zarin Tasnim Lalin, Nazmus Shakib |
| author_facet | Malakar, Tonmoy Amina, Miss Nourin Nurain Nijhum, Zarin Tasnim Lalin, Nazmus Shakib |
| contents | In this study, we present a highly sensitive Surface Plasmon Resonance (SPR)-based biosensor integrated with a circular-lattice Photonic Crystal Fiber (PCF) for early-stage cancer detection. The proposed sensor leverages the synergy between SPR and PCF technologies to overcome the bulkiness and limited sensitivity of traditional SPR systems. A thin gold (Au) layer, responsible for plasmon excitation, is deposited on the fiber structure, while a nanolayer of vanadium pentoxide (V2O5) is introduced to enhance adhesion between the gold and the silica background, improving structural stability and field confinement. The sensor is designed to detect refractive index (RI) variations in biological analytes, specifically targeting cancerous cells from skin, blood, and adrenal gland tissues. The optical characteristics and performance of the sensor were thoroughly analyzed using the Finite Element Method (FEM) in COMSOL Multiphysics 6.1, allowing for precise simulation and optimization. The sensor demonstrates high sensitivity within the RI range of 1.360-1.395, corresponding to the RI values of the target cancer cells. Remarkable wavelength sensitivities of 21,250 nm/RIU, 53,571 nm/RIU, and 103,571 nm/RIU were achieved for skin, blood, and adrenal gland cancers, respectively. In addition, a maximum figure of merit (FOM) of 306.424 RIU^-1 and a spectral resolution (SR) of 9.57x10^-7 RIU further affirm the sensor's exceptional detection capabilities. These findings indicate the proposed SPR-PCF sensor's strong potential for real-time, label-free biosensing applications, particularly in precise and early cancer diagnostics. |
| format | Preprint |
| id |
arxiv_https___arxiv_org_abs_2510_17283 |
| institution | arXiv |
| publishDate | 2025 |
| record_format | arxiv |
| spellingShingle | Optimized Single-Core PCF-Based SPR Biosensor for High-Performance Early-Stage Multi-Cancer Detection Malakar, Tonmoy Amina, Miss Nourin Nurain Nijhum, Zarin Tasnim Lalin, Nazmus Shakib Medical Physics Computational Physics Optics In this study, we present a highly sensitive Surface Plasmon Resonance (SPR)-based biosensor integrated with a circular-lattice Photonic Crystal Fiber (PCF) for early-stage cancer detection. The proposed sensor leverages the synergy between SPR and PCF technologies to overcome the bulkiness and limited sensitivity of traditional SPR systems. A thin gold (Au) layer, responsible for plasmon excitation, is deposited on the fiber structure, while a nanolayer of vanadium pentoxide (V2O5) is introduced to enhance adhesion between the gold and the silica background, improving structural stability and field confinement. The sensor is designed to detect refractive index (RI) variations in biological analytes, specifically targeting cancerous cells from skin, blood, and adrenal gland tissues. The optical characteristics and performance of the sensor were thoroughly analyzed using the Finite Element Method (FEM) in COMSOL Multiphysics 6.1, allowing for precise simulation and optimization. The sensor demonstrates high sensitivity within the RI range of 1.360-1.395, corresponding to the RI values of the target cancer cells. Remarkable wavelength sensitivities of 21,250 nm/RIU, 53,571 nm/RIU, and 103,571 nm/RIU were achieved for skin, blood, and adrenal gland cancers, respectively. In addition, a maximum figure of merit (FOM) of 306.424 RIU^-1 and a spectral resolution (SR) of 9.57x10^-7 RIU further affirm the sensor's exceptional detection capabilities. These findings indicate the proposed SPR-PCF sensor's strong potential for real-time, label-free biosensing applications, particularly in precise and early cancer diagnostics. |
| title | Optimized Single-Core PCF-Based SPR Biosensor for High-Performance Early-Stage Multi-Cancer Detection |
| topic | Medical Physics Computational Physics Optics |
| url | https://arxiv.org/abs/2510.17283 |